Use of Cannabis Products for the Management of Pain Associated With Gynecologic Conditions

Better-quality data on the use of cannabis products are needed. There are insufficient data to make a recommendation regarding the use of these products for management of pain associated with gynecologic conditions.

Clinicians should be aware of the possibility of patients' use of cannabis products for pain management and be prepared to counsel them about the theoretical benefits based on the endocannabinoid pathway, potential adverse effects, and the limitations of the data on the use of the cannabis products for the management of gynecologic pain.

Limited, low-quality survey data show that cannabis use may lead to decreased use of opioids. However, more data are needed before cannabis products can be substituted for other pain medications.